Challenges facing early infant diagnosis of HIV among infants in resource poor settings

Wasiu O Adebimpe1

  • 1Department of Community Medicine, College of Health Sciences, Osun State University, Osogbo. lekanadebimpe@gmail.com

Insights

Early infant diagnosis of HIV significantly improves survival rates in children. This review explores the challenges in implementing early HIV diagnosis programs in Nigeria.

Area of Science:

  • Public Health
  • Pediatrics
  • Infectious Diseases

Background:

  • The global incidence of pediatric Human Immunodeficiency Virus (HIV) is increasing.
  • Early diagnosis and management of HIV in infants are crucial for survival and mortality reduction.
  • Polymerase Chain Reaction (PCR) technology has enhanced the reliability and accessibility of early infant diagnosis of HIV.

Purpose of the Study:

  • To review the challenges encountered in the implementation of early infant diagnosis (EID) of HIV in Nigeria.
  • To identify barriers to prompt identification and enrollment into care for HIV-exposed infants in the Nigerian health system.

Main Methods:

  • A review of existing literature and program data on early infant diagnosis of HIV in Nigeria.
  • Analysis of health system challenges impacting EID program effectiveness.

Main Results:

  • HIV programs in Nigeria, like many developing countries, are heavily reliant on donor funding, hindering local sustainability.
  • Significant health system challenges impede the effective implementation of EID programs.
  • Difficulties exist in promptly identifying HIV-exposed infants and enrolling them into necessary care.

Conclusions:

  • Addressing the identified challenges is critical for improving early infant diagnosis of HIV in Nigeria.
  • Strengthening local health system capacity and promoting program sustainability are essential for better child survival outcomes.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...